Karen Oldfield
Overview
Explore the profile of Karen Oldfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamb R, Kerse K, Kristono H, Oldfield K, Beasley R
Respirology
. 2024 Aug;
29(10):922-923.
PMID: 39129181
No abstract available.
2.
Barry T, Holliday M, Sparks J, Biggs R, Colman A, Lamb R, et al.
ERJ Open Res
. 2024 Apr;
10(2).
PMID: 38590934
Background: Asthma is the most common chronic childhood respiratory condition globally. Inhaled corticosteroid (ICS)-formoterol reliever-based regimens reduce the risk of asthma exacerbations compared with conventional short-acting β-agonist (SABA) reliever-based regimens...
3.
Hatter L, Houghton C, Bruce P, Holliday M, Eathorne A, Pavord I, et al.
BMJ Open Respir Res
. 2022 Aug;
9(1).
PMID: 36007980
Background: In randomised controlled trials, as-needed inhaled corticosteroid (ICS)-formoterol reliever therapy reduces severe exacerbation risk compared with maintenance ICS plus short-acting beta-agonist (SABA) reliever in adolescent and adult asthma, but...
4.
Kearns C, Murton S, Oldfield K, Anderson A, Eathorne A, Beasley R, et al.
J Vis Commun Med
. 2022 Aug;
45(4):234-241.
PMID: 35942869
Drawing has played a key role in the development and dissemination of Medicine and Surgery, such as to share anatomy, pathology, and techniques for clinical interventions. While many of the...
5.
Chen H, Kunder R, Zou Y, Staton T, Zhu R, Galanter J, et al.
Pulm Pharmacol Ther
. 2022 Jun;
75:102133.
PMID: 35644305
Background: Janus Kinases (JAKs) mediate activity of many asthma-relevant cytokines. GDC-0214, an inhaled small molecule JAK1 inhibitor, has previously been shown to reduce fractional exhaled nitric oxide (FeNO) in patients...
6.
Bhagavan C, Kung S, Doppen M, John M, Vakalalabure I, Oldfield K, et al.
CNS Drugs
. 2020 Nov;
34(12):1217-1228.
PMID: 33244728
Background: Insomnia is associated with significant comorbidity, disability and impact on quality of life and, despite advances in pharmacotherapy and psychotherapy, remains a significant burden to society. Cannabinoids are gaining...
7.
Oldfield K, Eathorne A, Tewhaiti-Smith J, Beasley R, Semprini A, Braithwaite I
Postgrad Med J
. 2020 Nov;
98(1155):35-42.
PMID: 33218966
Purpose Of Study: To explore the experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in New Zealand doctors in an oncology setting. Study Design: An...
8.
Oldfield K, Ryan J, Doppen M, Kung S, Braithwaite I, Newton-Howes G
Australas Psychiatry
. 2020 Nov;
29(1):88-96.
PMID: 33174758
Objectives: To review the literature regarding label accuracy and contamination of medical cannabinoid-based products. Methods: A systematic review with meta-analysis following PRISMA guidelines. This study is registered with PROSPERO (CRD42019131565)....
9.
Papi A, Braithwaite I, Ebmeier S, Hancox R, Harrison T, Holliday M, et al.
Eur Respir J
. 2020 Oct;
57(2).
PMID: 33060151
No abstract available.
10.
Oldfield K, Eathorne A, Maijers I, Beasley R, Semprini A, Braithwaite I
N Z Med J
. 2020 Sep;
133(1522):96-111.
PMID: 32994620
Aim: To determine what patients presenting to general practice (GP) understand about the use of cannabis as a medicine, beliefs of how this may impact their medical conditions and interactions...